en
Scientific article
English

ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia

Published inPharmacogenomics, vol. 12, no. 10, p. 1493-1501
Publication date2011
Abstract

To examine the safety profile of oseltamivir in children and evaluate the impact of P-glycoprotein polymorphisms on the incidence of neuropsychiatric adverse events (NPAE) in oseltamivir-treated children.

Keywords
  • Adolescent
  • Antiviral Agents/adverse effects/therapeutic use
  • Blood-Brain Barrier/drug effects
  • Capillary Permeability/drug effects/genetics
  • Child
  • Child, Preschool
  • Humans
  • Infant
  • Infant, Newborn
  • Influenza A Virus, H1N1 Subtype
  • Influenza, Human/drug therapy
  • Mental Disorders/chemically induced/genetics
  • Oseltamivir/adverse effects/therapeutic use
  • P-Glycoprotein/genetics
  • Pandemics
  • Polymorphism, Single Nucleotide
Citation (ISO format)
L’HUILLIER, Arnaud et al. ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia. In: Pharmacogenomics, 2011, vol. 12, n° 10, p. 1493–1501. doi: 10.2217/pgs.11.91
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1462-2416
866views
6downloads

Technical informations

Creation12/17/2012 3:32:00 PM
First validation12/17/2012 3:32:00 PM
Update time03/14/2023 7:58:40 PM
Status update03/14/2023 7:58:40 PM
Last indexation05/02/2024 12:58:29 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack